Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma - Omata, M. / Okita, K. (eds.)
139,09 €
versandkostenfrei*

inkl. MwSt.
Versandfertig in 3-5 Tagen
0 °P sammeln
    Gebundenes Buch

The first single-topic annual conference on hepatology in Japan was held in November 2002 to discuss therapies for viral hepatitis and the prevention of hepatocellular carcinoma (HCC). Bringing together researchers and clinicians from North America, Europe, Japan, and other parts of Asia, the conference included symposia on the hepatitis C replicon system, new antivirals that lower or prevent the incidence of HCC, and transplantation in cases of hepatitis B and C, as well as new treatment modalities for viral hepatitis and preventative measures for HCC. With the rising number of HCC cases…mehr

Produktbeschreibung
The first single-topic annual conference on hepatology in Japan was held in November 2002 to discuss therapies for viral hepatitis and the prevention of hepatocellular carcinoma (HCC). Bringing together researchers and clinicians from North America, Europe, Japan, and other parts of Asia, the conference included symposia on the hepatitis C replicon system, new antivirals that lower or prevent the incidence of HCC, and transplantation in cases of hepatitis B and C, as well as new treatment modalities for viral hepatitis and preventative measures for HCC. With the rising number of HCC cases worldwide, this collection of papers presented at the conference provides a valuable, up-to-date resource and reference for all professionals involved in the treatment and prevention of viral hepatitis and hepatocellular carcinoma.
  • Produktdetails
  • Verlag: Springer, Berlin
  • 2004
  • Seitenzahl: 308
  • Erscheinungstermin: 19. Januar 2004
  • Englisch
  • Abmessung: 241mm x 160mm x 21mm
  • Gewicht: 630g
  • ISBN-13: 9784431402800
  • ISBN-10: 4431402802
  • Artikelnr.: 12633378
Autorenporträt
Kiwamu Okita Professor, Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine
Inhaltsangabe
Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma.- Lamivudine Therapy for Hepatitis B.- New Anti-virals: HBV.- Therapy for Hepatitis B and Prevention of HCC.- HCV Replicon System.- New Anti-virals: HCV.- Interferon Therapy for Hepatitis C.- Therapy for Hepatitis C and Prevention of HCC.- Chemoprevention and Therapy for HCC.- Transplantation for HBV and HCV.